Grace Therapeutics, Inc. GRCE

GRCE Company Overview

Grace Therapeutics, Inc. (Nasdaq: GRCE) is a specialty pharmaceutical company focused on developing and commercializing therapies for neurological and rare diseases with significant unmet medical needs. The company’s primary focus has been on drug delivery technologies and reformulations intended to improve treatment administration, safety, and clinical outcomes in acute care and central nervous system-related indications. Grace Therapeutics operates within the broader biotechnology and specialty pharmaceutical industries, with emphasis on hospital-based and specialty care markets.

The company evolved through a series of strategic restructurings and acquisitions associated with its predecessor operations in the biopharmaceutical sector. Public filings indicate that the company transitioned its strategic focus toward late-stage neurology and hospital-based therapeutics after earlier activities in cardiovascular and lipid-management drug development. Its positioning has centered on acquiring or advancing differentiated pharmaceutical assets that may qualify for regulatory exclusivity, orphan-drug opportunities, or specialized clinical use cases.